Theravance Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $374.8M
Liabilities Breakdown FY2021
Total Liabilities: $713.4M
Asset Breakdown
Total Assets: $374.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $90.0M | 24.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $13.7M | 3.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $271.2M | 72.4% |
Liabilities Breakdown
Total Liabilities: $713.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.1M | 0.4% |
| Long-Term Debt | $616.3M | 86.4% |
| Other Liabilities | $94.0M | 13.2% |